Women in combat: The effects of combat exposure and gender on the incidence and persistence of posttraumatic stress disorder diagnosis.


Journal

Journal of psychiatric research
ISSN: 1879-1379
Titre abrégé: J Psychiatr Res
Pays: England
ID NLM: 0376331

Informations de publication

Date de publication:
01 2021
Historique:
received: 18 06 2020
revised: 17 11 2020
accepted: 01 12 2020
pubmed: 11 12 2020
medline: 15 5 2021
entrez: 10 12 2020
Statut: ppublish

Résumé

Recent expansions in the roles of women in combat have prompted increased interest in the psychological toll combat exposure may have on female service members as compared to males. This study examined the interactive effects of gender and combat exposure on transitions in posttraumatic stress disorder (PTSD) diagnostic status (presence or absence of PTSD diagnosis). We used administrative data of 20,000 U.S. Army soldiers whose combat exposure was assessed after return from deployment between January 1, 2008 and June 30, 2014; soldiers' PTSD diagnostic status was determined using International Classification of Diseases-9 diagnoses at four time points separated by 12 months. We used a mixed-effects logit transition model to examine the effects of combat and gender on incidence, persistence, and prevalence of PTSD diagnosis. Incidence and prevalence of PTSD diagnosis were higher among women, but persistence of PTSD diagnosis was higher in men. Higher rates of new PTSD diagnosis among women were not dependent on combat exposure, suggesting that other types of trauma may be responsible for increased rates among women. Gender differences in prevalence and persistence of PTSD diagnosis were greater among combat-exposed soldiers than among those not exposed to combat. Men maintained a PTSD diagnosis over longer periods of time than women suggesting greater PTSD persistence, and this pattern was particularly pronounced among soldiers exposed to combat. These results have implications for the recent policy changes and gender-based prevention strategies, and suggest that women in combat roles may be no more vulnerable to PTSD than are their male counterparts. Though the gender differences were small, they are indicative of healthcare utilization patterns that may be important for prevention and that warrant further exploration.

Identifiants

pubmed: 33302161
pii: S0022-3956(20)31118-3
doi: 10.1016/j.jpsychires.2020.12.010
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

16-22

Informations de copyright

Copyright © 2020 Elsevier Ltd. All rights reserved.

Auteurs

Marija Spanovic Kelber (MS)

Psychological Health Center of Excellence, Defense Health Agency, Falls Church, VA, USA. Electronic address: marija.s.kelber.ctr@mail.mil.

Xian Liu (X)

Psychological Health Center of Excellence, Defense Health Agency, Falls Church, VA, USA.

Kevin O'Gallagher (K)

Psychological Health Center of Excellence, Defense Health Agency, Falls Church, VA, USA.

Lindsay Thonsen Stewart (LT)

Psychological Health Center of Excellence, Defense Health Agency, Falls Church, VA, USA.

Bradley E Belsher (BE)

Psychological Health Center of Excellence, Defense Health Agency, Falls Church, VA, USA; Uniformed Services University of the Health Sciences, Bethesda, MD, USA.

Maria A Morgan (MA)

Psychological Health Center of Excellence, Defense Health Agency, Falls Church, VA, USA.

Don E Workman (DE)

Psychological Health Center of Excellence, Defense Health Agency, Falls Church, VA, USA; Uniformed Services University of the Health Sciences, Bethesda, MD, USA.

Nancy A Skopp (NA)

Psychological Health Center of Excellence, Defense Health Agency, Falls Church, VA, USA.

Kate McGraw (K)

Psychological Health Center of Excellence, Defense Health Agency, Falls Church, VA, USA.

Daniel P Evatt (DP)

Psychological Health Center of Excellence, Defense Health Agency, Falls Church, VA, USA; Uniformed Services University of the Health Sciences, Bethesda, MD, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH